Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Structure Therapeutics Inc. GPCR

Set alert

Price alert · GPCR

All alert types
20.47 USD -1.40 -6.40%

At close

21.05 +0.58 +2.85%

Pre-market · Nov 3, 7:09 AM ET

Bid
20.41 × 1
Ask
20.50 × 1
20.42 Day range 22.05
20.42 52-week range 94.90
YTD
-70.57%
1 year
-37.52%
Open
21.57
Prev close
21.87
Mkt cap
1.46B
Vol
788.35K
Avg vol
1.10M
EPS
-3.03
P/E
0.00
Div yield
0.00%
More statistics
Low
20.42
High
22.05
Forward P/E
-9.69
Beta
-1.20
Short ratio
4.76
Inst. own
97.61%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
33.44
200-d avg
49.06
1y target
107.29

5D chart

Chart tools
Interval
1m5m15m30m

Signals (131)
NameTimeAgo
MACD: Sell SignalNov 2, 3:35 PM16 hours ago
SMA: BearishNov 2, 3:20 PM16 hours ago
SMA: BearishNov 2, 3:20 PM16 hours ago
SMA: BullishNov 2, 3:15 PM16 hours ago
SMA: BearishNov 2, 3:10 PM16 hours ago
SMA: BullishNov 2, 2:55 PM16 hours ago
SMA: BullishNov 2, 2:50 PM16 hours ago
SMA: BearishNov 2, 2:45 PM16 hours ago
MACD: Buy SignalNov 2, 2:45 PM16 hours ago
SMA: BullishNov 2, 2:40 PM17 hours ago
RSI: OversoldNov 2, 2:20 PM17 hours ago
SMA: BearishNov 2, 2:15 PM17 hours ago
MACD: Sell SignalNov 2, 2:15 PM17 hours ago
SMA: BullishNov 2, 2:05 PM17 hours ago
MACD: Buy SignalNov 2, 2:00 PM17 hours ago
RSI: OversoldNov 2, 1:50 PM17 hours ago
MACD: Sell SignalNov 2, 1:45 PM17 hours ago
SMA: BearishNov 2, 1:10 PM18 hours ago
SMA: BullishNov 2, 1:05 PM18 hours ago
SMA: BearishNov 2, 12:20 PM19 hours ago

Newest 20 of 131.

Analyst view

Consensus: none

Price target (mean) 107.29 +424.1% upside
Target (low)
70.00
Target (mean)
107.29
Target (high)
145.00
Ratings (0m) 16 15 buy · 1 hold · 0 sell
  • Strong buy4
  • Buy11
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 16
  • 1 month ago 16
  • 2 months ago 16

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

GPCR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.241-0.57 – 2.02-0.37+34.9%50.00M0.0%10
Next quarter-0.49-0.59 – -0.280.20-345.0%00.0%10
Current year-1.62-2.04 – 0.94-0.80-102.0%41.67M0.0%11
Next year-2.19-2.53 – -1.57-1.62-35.2%45.45K-99.9%9

Upgrades and downgrades

The latest rating changes

GPCR analyst upgrades and downgrades
DateFirmActionFromTo
Sep 9, 2026CitizensReiteratedMarket OutperformMarket Outperform
Aug 7, 2026CitigroupMaintainedBuyBuy
Aug 7, 2026CitizensMaintainedMarket OutperformMarket Outperform
Jun 11, 2026HC Wainwright & Co.MaintainedBuyBuy
Apr 27, 2026Canaccord GenuityInitiated—Buy
Mar 16, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 2, 2026HC Wainwright & Co.MaintainedBuyBuy
Feb 27, 2026CitizensMaintainedMarket OutperformMarket Outperform
Jan 22, 2026JP MorganMaintainedOverweightOverweight
Jan 20, 2026GuggenheimMaintainedBuyBuy
Dec 19, 2025HC Wainwright & Co.MaintainedBuyBuy
Dec 12, 2025Morgan StanleyMaintainedOverweightOverweight
Dec 12, 2025CitizensMaintainedMarket OutperformMarket Outperform
Dec 11, 2025JefferiesMaintainedBuyBuy
Dec 9, 2025CitigroupMaintainedBuyBuy
Dec 9, 2025StifelMaintainedBuyBuy
Dec 9, 2025Clear StreetMaintainedBuyBuy
Aug 7, 2025HC Wainwright & Co.MaintainedBuyBuy
Aug 7, 2025GuggenheimMaintainedBuyBuy
Aug 7, 2025JMP SecuritiesMaintainedMarket OutperformMarket Outperform
Jun 23, 2025Cantor FitzgeraldReiteratedOverweightOverweight
Jun 23, 2025JMP SecuritiesReiteratedMarket OutperformMarket Outperform
May 12, 2025HC Wainwright & Co.MaintainedBuyBuy
May 2, 2025CitigroupInitiated—Buy
Apr 22, 2025HC Wainwright & Co.MaintainedBuyBuy
Feb 28, 2025Citizens Capital MarketsMaintainedMarket OutperformMarket Outperform
Feb 28, 2025William BlairInitiated—Outperform
Jan 8, 2025StifelInitiated—Buy
Dec 20, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 19, 2024HC Wainwright & Co.ReiteratedBuyBuy